From MarketBeat:

Raymond James Financial Services raised its stake in Zoetis Inc., acquiring 165,588 shares worth $28,809,000. Other large fund investors, like Fairfield Bush & CO. and Sequoia Financial Advisors LLC, also increased their positions in Zoetis. Zoetis Inc. expects to post 5.41 earnings per share for the current year and has a price-to-earnings ratio of 39.44.

Shares of ZTS stock opened at $194.04 on Friday. The firm has a market capitalization of $89.09 billion.

Zoetis Inc. last announced its quarterly earnings results, reporting $1.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.35 by $0.01. The company had revenue of $2.15 billion during the quarter.

Zoetis Inc. also recently announced an increased quarterly dividend of $0.432, boosting its annual dividend to $1.73, with a yield of 0.89%.

Corporate insiders, including EVP Roxanne Lagano and CEO Kristin C. Peck, recently sold shares of Zoetis stock worth millions of dollars. In the last 90 days, insiders sold 17,346 shares of company stock worth $3,122,321.

Several equities analysts have issued reports on Zoetis, with eight analysts giving the stock a buy rating and one issuing a strong buy rating. The stock currently has a consensus rating of “Buy” and an average price target of $220.11.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It focuses on livestock and companion animals, with a diverse product portfolio.



Read more: Raymond James Financial Services Advisors Inc. Has $28.81 Million Stock Position in Zoetis Inc. (NYSE:ZTS)